BIO
Bio-Rad Laboratories A·NYSE
--
--(--)
--
--(--)
7.16 / 10
Outperform
Sentiment is positive (7.16/10) with strong fund inflows (7.95). Overall, block and extra‑large investors are net buyers, while medium and large show outflows. Analyst coverage is limited: 50% Strong Buy, 50% Neutral, with mixed historical performance. Bias leans bullish.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-10-30
InstitutionWells Fargo
Times predicted4
Historical Win Rate75.0%
What is the analyst consensus for BIO?
- BIO holds a Bullish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.16/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
